Purpose

The Neuromodulation Foundation, a charitable, tax-exempt organization incorporated in Maryland in August 2007, contributes to the improvement of the health of patients suffering from pain and debilitating neurological conditions by providing education about neuromodulation and by reporting the results of scientific research in this field.

Board of Directors & Staff

Richard B. North, MD, President of the Foundation, is joined on the Board by Vice President Peter Gaskins, MBA; B. Todd Sitzman, MD, MPH; Konstantin V. Slavin, MD; and the Executive Director, Jane Shipley, BA (ex-officio). Ms. Shipley is the only paid employee.

Programs

WIKISTIM.org

This website represents one of the major areas in which the Foundation is providing information to educate physicians and the public. 

The Spinal Cord Stimulation Glossary

The glossary that appears on this website is undergoing an update. We first published this glossary in 2007 in Pain Medicine and put it online when we created WIKISTIM.org. In order to begin the process of keeping the glossary current, we worked with volunteer experts representing the Institute of Neuromodulation and the International Neuromodulation Society (INS) and published an updated version on-line and in print in the journal Neuromodulation in 2021. We are currently meeting with authors of the original publication and new contributors, 12 overall, to review plans for a reformatted, updated online glossary. Notably, this will expand beyond the space constraints of the print edition, but the scope, inclusions/exclusion criteria, and target audience will remain substantially the same.

Consulting

Dr. North and Ms. Shipley also consult with researchers and present talks on such topics as the cost-effectiveness of spinal cord stimulation, best practices in study design, and the application of evidence-based medicine in the field of neuromodulation.

Funding

Since its inception in 2007, the Neuromodulation Foundation has received support in the form of donations, grants, and/or consulting contracts from Autonomic Technologies, Bioness, Biotronik, Boston Scientific, Enterra, Greatbatch, the International Neuromodulation Society, the Donlin & Harriett Long Family Charitable Gift Fund, the Institute of Neuromodulation, the International Neuromodulation Society, Medtronic, Microtransponder, the Neuromodulation Therapy Access Coalition, the NANS Foundation, the North American Neuromodulation Association, Nevro, Nuvectra, Sinai Hospital of Baltimore, St. Jude Medical, Stimwave, and the following individuals: Thomas Abell, MD; James Brennan, MD; Allen Burton, MD; David Cedeno, PhD, & Pilar Mejia, PhD; Kenneth Chapman, MD; Terry Daglow; Hemant Kalia, MD, MPH, FIPP; SuEarl McReynolds; Richard B. North, MD; Mohammad Omer; Louis Raso, MD, PA; Sean Slee, MD; B. Todd Sitzman, MD, MPH; and Konstantin Slavin, MD.   

Contact